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Abstract
The use of cardiopulmonary bypass as an adjunct to airway surgery for non-malignant diseases in
adults is not well established in the UK. We are reporting two cases which demonstrate the
additional benefits of using cardiopulmonary bypass during difficult bronchoscopy and complex
airway stenting. The first case presents an emergency indication for cardiopulmonary bypass in a
life-threatening but benign condition. The second case presented, utilises cardiopulmonary bypass
standby as adjunct to a potentially life threatening procedure. A review of the literature is also
provided.
Background
Although the use of cardiopulmonary bypass (CPB) is
well established for interventions to treat tracheal stenosis
in children, its use during bronchoscopy or tracheal pro-
cedures has been less frequently reported in adults. Its use
as a standby adjunct to bronchoscopy and tracheal stent-
ing has rarely been reported in the UK.
We would like to report an additional use for CPB for sup-
port during bronchoscopy and tracheal stenting for non-
malignant diseases.
Case 1
A 56 year old man presented with progressively worsening
dyspnoea at rest. There was no history of chronic lung dis-
ease or cyanosis. On examination, he was found to have
bilateral chest rhonchi and absent nasal cartilages. Inves-
tigation showed reduced FEV1 to 0.8 litres (23% pre-
dicted), and within normal basic blood tests. His
medications included Prednisolone, Salbutamol and
Seretide inhalers, and he was taking Mucolyn syrup regu-
larly. Clinical diagnosis at time of referral was Relapsing
Polychondritis, which was further supported by the bron-
choscopy findings and a CT scan showing tracheobron-
chial thickening [1,2]. He underwent endobronchial
stenting with a self-expanding metal stent (The Ultraflex™
Tracheobronchial Stent System, Boston Scientific, MA,
US) in December 2005 to the trachea and separately to the
left main bronchus; post operatively he was well and was
discharged after 2 days.
On subsequent review his symptoms showed minimum
improvement and his exercise tolerance was approxi-
mately 100 yards on the flat. Six months after his first
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bronchoscopy and stenting he had a silicon stent (The
TRACHEOBRONXANE®  Dumon®  Silicone Stent,
Novatech SA, France) inserted into the bronchus interme-
dius on the right side. During that procedure a subglottic
stricture was noted and his airway was found to be very
collapsible. Just prior to his planned discharge, he devel-
oped noticeable stridor and therefore the stent had to be
removed urgently. He deteriorated to type 1 respiratory
failure for which he was admitted to the Intensive Care
Unit where he was intubated and ventilated. He was extu-
bated and managed with CPAP in High Dependency Unit
the following day. Unfortunately, his breathing became
more laboured overnight, leading to readmission to
Intensive Care Unit and intubation with an un-cuffed pae-
diatric endotrachial tube. A second bronchoscopy was
performed and showed significant oedema of the vocal
cords, a subglottic stenosis, and the airway stents
remained in good position. The distal trachea and right
main bronchus were collapsing. There were relatively few
secretions, and no evidence of infection. Following his
second bronchoscopy and immediately after extubation,
he again became hypoxic and witnessed a cardiorespira-
tory arrest from which he was successfully resuscitated.
He was taken to theatre, as an emergency, and CPB estab-
lished through right femoral vessels cannulation. Tran-
soesophageal echo was used for control of placement of
the long venous cannula. Intra-operative bronchoscopy
confirmed collapsing distal trachea. The right and left
main bronchi were now seen with copious secretions
which were aspirated. A 12 mm × 2 cm uncovered
Ultraflex stent was inserted into the bronchus interme-
dius, and a percutaneous tracheostomy set was used to
assist in performing an open tracheostomy. He was
weaned from the CPB after 81 minutes, decannulated and
the femoral vessels repaired.
He was weaned off the ventilator support over a two week
period. Eventually, he required a transfer to a rehabilita-
tion centre. His follow up at six months included a review
by an ENT surgeon.
Case 2
A 53 year old female with a longstanding high laryngo-tra-
cheal post-intubation stenosis underwent elective follow-
up bronchoscopy. She was fourteen years post-intubation
for multitrauma. In February 2005 she underwent trache-
ostomy for worsening dyspnoea secondary to tracheo-
bronchitis after Staphylococcal sepsis. Her past history
was significant for right breast cancer, for which she had
mastectomy and chemo-radiotherapy, and pneumotho-
rax as a child.
Bronchoscopy showed severe narrowing of the left main
bronchus (Figure 1). Stenting was not attempted at that
time, as inflamed mucosa was seen to predispose to bleed-
ing which would have made airway management through
the tracheostomy difficult.
Her preoperative electrocardiogram and her routine
bloods including full blood count, urea and electrolytes,
creatinin, cardiac enzymes, liver function tests and coagu-
lation profile were within the normal range. She under-
went elective bronchoscopy and stenting with Ultraflex, to
the left main bronchus with CPB on standby. As a precau-
tionary measure, just prior to airway intervention, the
femoral vessels were exposed for potential cannulation.
The bronchoscopic procedure was without complications
and therefore CPB was not actually required (Figure 2).
Discussion
Airway stenting has an important palliative role in malig-
nant disease processes. Its usefulness in benign large air-
way disorders is less well defined. Non-resectable or
systemic diseases with benign aetiology causing airway
disruption may require high risk bronchoscopy. Airway
procedures in this setting carry potential risks, including
desaturation, respiratory failure, airway bleeding, stent
dislodgement and inability to intubate or establish a
definitive airway. Airway manipulation predisposes to
other complications, including restenosis, granulation tis-
sue formation, stent migration, metal fatigue, mucus
plugging, and halitosis [3,4].
A CT scan section of case 2, showing severe stenosis of left  main bronchus Figure 1
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Over half a century, CPB has been refined and used for
multiple cardiac and various non-cardiac indications [5].
Since then, CPB equipments have enabled surgeons to
perform increasingly complex cardiac and other challeng-
ing operations [6]. The use of cardiopulmonary bypass to
aid surgery for tracheal procedures is more frequently
reported in infants and children than in adult population.
There are indications that reports in the literature explor-
ing its use in managing tracheal stenosis in adults are on
the increase [7]. The use of CPB is potentially associated
with postoperative pulmonary insults, ranging from mild
dyspnoea to florid adult respiratory distress syndrome
(ARDS) in 1–2% of cases, which in itself carries a 50%
mortality rate [8].
To our knowledge there are no clinical reviews in the Eng-
lish literature on the use of CPB in airway management in
general, or in airway stenting in particular. Furthermore,
most of the published case reports or case series were on
the use of femoral-femoral CPB or percutaneous cardiop-
ulmonary support (PCPS) in difficult or compromised
airways in tumour-related conditions. These case reports
advocate the safe use of femoral-femoral CPB and PCPS in
the management of airway obstruction [9-12]. A few case
reports from Japan, concerning patients who underwent
endotracheal stenting for advanced malignancy utilizing
PCPS or Extracorporeal Lung Assist (ECLA) perfusion,
have been published [13,14]. The use of PCPS in the pal-
liative surgical management of carcinomatous involve-
ment of the carina to support gas exchange has also been
reported from Japan. This allows safe bilateral bronchial
dilatation and stenting [15]. Unfortunately, many case
reports and case series from Japan are not published in
English except for the abstract [16-18].
The cases presented here advocate the safe use of extracor-
poreal lung support for the treatment of otherwise inoper-
able tracheal stenoses. Palliative stenting in advanced
malignancy is controversial in absence of curative
options. In the cases presented here, we found that CPB is
safe and useful as a standby during complex stenting pro-
cedures for benign tracheo-bronchial conditions with bet-
ter long term prognosis.
Conclusion
Utilising support of cardiopulmonary bypass during high
risk tracheobronchial interventions for benign diseases is
controversial but can be safely applied and can be life sav-
ing.
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